Bone Development and Growth Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Bone Development and Growth. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Bone Development and Growth Indian Medical PG Question 1: Achondroplasia shows which type of inheritance?
- A. X-linked dominant (XLD)
- B. Autosomal recessive inheritance
- C. Autosomal dominant inheritance (Correct Answer)
- D. X-linked recessive (XLR)
Bone Development and Growth Explanation: ***Autosomal dominant inheritance***
- Achondroplasia is caused by a **mutation in the FGFR3 gene**, which is located on an **autosomal chromosome** (chromosome 4).
- The disease manifests with only **one copy of the mutated gene**, hence it follows an autosomal dominant pattern.
*X-linked dominant (XLD)*
- X-linked dominant disorders are caused by mutations on the **X chromosome** and typically affect females more severely or frequently than males.
- Achondroplasia does not show sex-linked inheritance patterns, as its causative gene is on an autosome.
*Autosomal recessive inheritance*
- Autosomal recessive disorders require **two copies of the mutated gene** (one from each parent) for the disease to manifest.
- Achondroplasia can occur with only one copy of the mutated gene, distinguishing it from recessive inheritance.
*X-linked recessive (XLR)*
- X-linked recessive disorders primarily affect **males** and are carried by females, who are usually asymptomatic carriers.
- The inheritance pattern of achondroplasia is independent of sex, ruling out X-linked recessive inheritance.
Bone Development and Growth Indian Medical PG Question 2: Osteochondroma arises from which part of the bone?
- A. Medullary cavity
- B. Diaphysis
- C. Metaphysis (Correct Answer)
- D. Epiphysis
Bone Development and Growth Explanation: ***Metaphysis***
- **Osteochondromas** are outgrowths of bone and cartilage that typically arise from the **metaphyseal regions** of long bones, such as the distal femur, proximal tibia, and proximal humerus.
- This region is characterized by active **endochondral ossification**, which is the process interrupted in the formation of ostecochondromas.
*Medullary cavity*
- The **medullary cavity** contains bone marrow and is not the primary site of origin for osteochondromas, which are exophytic lesions.
- While some tumors can extend into the medullary cavity, their origin is generally from the outer bone surfaces rather than the central cavity.
*Diaphysis*
- The **diaphysis** is the main or mid-section of a long bone (the shaft), and it is primarily composed of compact bone, with less active growth than the metaphysis.
- Though osteochondromas can occur in the diaphysis, they are far less common than in the metaphysis, which is the site of rapid bone growth.
*Epiphysis*
- The **epiphysis** is the end part of a long bone, initially separated from the main bone by cartilage but later fusing with it.
- While it's a site of growth, osteochondromas are very rarely found in the epiphysis, as their growth mechanism is more closely linked to the **physeal plate** located in the metaphysis.
Bone Development and Growth Indian Medical PG Question 3: Bone mass is reduced in all of the following conditions EXCEPT:
- A. Osteoporosis
- B. Osteopetrosis (Correct Answer)
- C. Hyperparathyroidism
- D. Osteomalacia
Bone Development and Growth Explanation: **Osteopetrosis**
- **Osteopetrosis**, also known as **marble bone disease**, is a rare genetic disorder characterized by **increased bone density** due to defective osteoclast function.
- In this condition, osteoclasts are unable to resorb bone, leading to an excessive accumulation of bone tissue, resulting in **densified but brittle bones**.
*Osteoporosis*
- **Osteoporosis** is characterized by significantly **reduced bone mass** and microarchitectural deterioration of bone tissue [1].
- This leads to increased bone fragility and a higher risk of fractures, as the bone becomes porous and weak [2].
*Hyperparathyroidism*
- **Hyperparathyroidism** causes **increased bone resorption** due to excessive parathyroid hormone (PTH) secretion.
- PTH mobilizes calcium from the bones, leading to a **decrease in bone density** and potential bone cysts (**osteitis fibrosa cystica**) [3].
*Osteomalacia*
- **Osteomalacia** is a condition where there is **defective mineralization of bone osteoid**, leading to softer bones [4].
- While the bone mass might appear structurally normal, the **mineral content is reduced**, making the bone weak and susceptible to bowing and fractures.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1189-1191.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 665-666.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, p. 1194.
[4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1194-1195.
Bone Development and Growth Indian Medical PG Question 4: What is the primary organic component of bone?
- A. 10% collagen
- B. 10% noncollagenous protein
- C. 20% noncollagenous protein
- D. 90% collagen protein (Correct Answer)
Bone Development and Growth Explanation: ***90% collagen protein***
- **Type I collagen** constitutes around 90% of the organic matrix of bone, providing its tensile strength and flexibility [1].
- This extensive collagen network forms the framework upon which **mineral crystals** (hydroxyapatite) are deposited [1].
*10% collagen*
- This percentage is significantly lower than the actual proportion of collagen in the organic matrix of bone.
- If collagen only represented 10%, bone would lack its characteristic **tensile strength** and elasticity [2].
*10% noncollagenous protein*
- While noncollagenous proteins like **osteocalcin** and **osteonectin** are important for bone mineralization and cell signaling, they only constitute about 10% of the *organic matrix*, not the entire bone, and are not the *primary organic component* [1].
- The dominant organic component is collagen, which provides the structural scaffold [1].
*20% noncollagenous protein*
- This percentage is inaccurate; **noncollagenous proteins** typically make up about 10% of the bone's organic matrix [1].
- A higher proportion of noncollagenous proteins would alter the bone's mechanical properties, potentially making it more brittle.
Bone Development and Growth Indian Medical PG Question 5: Which bone tumor involves the epiphysis?
- A. Osteosarcoma
- B. Giant cell tumor (Correct Answer)
- C. Ewing's sarcoma
- D. Multiple myeloma
Bone Development and Growth Explanation: ***Giant cell tumor***
- **Giant cell tumor (GCT)**, also known as osteoclastoma, characteristically arises in the **epiphysis** [1] or **metaphysis** of long bones in adults.
- It is a benign but locally aggressive tumor that often presents with pain, swelling, and reduced range of motion in the affected joint [1].
*Osteosarcoma*
- **Osteosarcoma** typically arises in the **metaphysis** of long bones, particularly around the knee (distal femur, proximal tibia).
- It is a highly malignant primary bone tumor characterized by the production of **osteoid** by tumor cells [2].
*Ewing's sarcoma*
- **Ewing's sarcoma** most commonly affects the **diaphysis** of long bones or flat bones (e.g., pelvis, scapula, ribs).
- It is characterized by small, round, blue cells and often presents with pain, swelling, and systemic symptoms like fever.
*Multiple myeloma*
- **Multiple myeloma** is a malignancy of **plasma cells** that primarily affects the **bone marrow** and can cause widespread osteolytic lesions.
- It typically presents in older adults and affects bones with active marrow, such as the vertebrae, ribs, skull, and pelvis, rather than being localized to the epiphysis as a primary bone tumor.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1205-1206.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 673-674.
Bone Development and Growth Indian Medical PG Question 6: All of the following physiological processes occur during growth at the epiphyseal plate except:
- A. Proliferation and hypertrophy
- B. Calcification and ossification
- C. Angiogenesis and remodeling
- D. Replacement of red bone marrow with yellow marrow (Correct Answer)
Bone Development and Growth Explanation: ***Replacement of red bone marrow with yellow marrow***
- The replacement of **red bone marrow** with **yellow marrow** is a process that occurs in the **diaphysis (shaft)** of long bones with aging, not directly within the **epiphyseal plate** during growth.
- While it's a normal physiological change in bone, it's distinct from the primary mechanisms of **longitudinal bone growth** occurring at the growth plate.
*Proliferation and hypertrophy*
- **Chondrocytes** in the **proliferative zone** of the epiphyseal plate divide rapidly, increasing in number.
- In the **hypertrophic zone**, these chondrocytes enlarge significantly, contributing to the lengthening of the bone.
*Calcification and ossification*
- The hypertrophied chondrocytes in the **calcification zone** undergo apoptosis, and their extracellular matrix becomes calcified.
- In the **ossification zone**, osteoblasts invade the calcified cartilage and lay down new bone matrix, replacing the cartilage with bone.
*Angiogenesis and remodeling*
- **Angiogenesis** (formation of new blood vessels) is essential for delivering osteoblasts and nutrients to the epiphyseal plate and removing chondrocytes.
- **Bone remodeling**, involving both bone formation and resorption, occurs as part of the ossification process to shape the new bone and maintain its structural integrity.
Bone Development and Growth Indian Medical PG Question 7: Systemic factor which is responsible for bone remodeling :
- A. Cytokines (e.g., IL-1, IL-6)
- B. Prostaglandin E2 (PGE2)
- C. PTH (Correct Answer)
- D. Transforming Growth Factor-beta (TGF-β)
Bone Development and Growth Explanation: ***PTH***
- **Parathyroid hormone (PTH)** is a major systemic regulator of bone remodeling, primarily influencing **calcium and phosphate homeostasis**.
- High levels of PTH, particularly prolonged or continuous elevation, stimulate **osteoclasts** directly or indirectly, leading to increased **bone resorption**.
*Cytokines (e.g., IL-1, IL-6)*
- These are primarily **local humoral factors** that regulate bone remodeling in a specific area, often in response to inflammation or injury.
- While they can influence bone metabolism, their action is generally more localized, unlike the widespread systemic effects of PTH.
*Prostaglandin E2 (PGE2)*
- **PGE2** is another **local mediator** involved in bone remodeling, produced by various cells including osteoblasts and osteocytes.
- It plays a role in both bone formation and resorption depending on concentration and context, but its effects are typically paracrine or autocrine rather than systemic endocrine control.
*Transforming Growth Factor-beta (TGF-β)*
- **TGF-β** is a potent **local growth factor** stored within the bone matrix and released during bone resorption.
- It regulates proliferation and differentiation of osteoblasts and osteoclasts, primarily acting as a local regulator of bone formation and repair rather than a systemic hormone.
Bone Development and Growth Indian Medical PG Question 8: All of the following produce osteoblastic secondaries except:
- A. Carcinoma of Prostate
- B. Carcinoma of Breast
- C. Carcinoid tumors
- D. Multiple myeloma (Correct Answer)
Bone Development and Growth Explanation: ***Multiple myeloma***
- Multiple myeloma is a **plasma cell malignancy** that typically causes **osteolytic (bone-destroying) lesions** due to the activation of osteoclasts and inhibition of osteoblasts, rather than osteoblastic (bone-forming) metastases [1].
- The bone lesions are often described as **punched-out lesions** on imaging [1].
*Carcinoma of Prostate*
- **Prostate cancer** is well-known for producing **osteoblastic (sclerotic)** bone metastases, characterized by new bone formation [2].
- This is mediated by factors secreted by prostate cancer cells that stimulate osteoblasts [2].
*Carcinoma of Breast*
- **Breast cancer** metastases to bone can be **mixed osteoblastic and osteolytic**, but frequently present with an osteoblastic component, especially in advanced stages.
- The type of bone lesion can be influenced by various signaling pathways between cancer cells and bone cells.
*Carcinoid tumors*
- **Carcinoid tumors**, particularly those of gastrointestinal origin, can cause **osteoblastic bone metastases**, sometimes presenting as sclerotic lesions.
- While less common than prostate or breast cancer, they are recognized for their potential to induce bone formation.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 616-618.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 501-502.
Bone Development and Growth Indian Medical PG Question 9: Inorganic component of bone is:
- A. 65% (Correct Answer)
- B. 85%
- C. 35%
- D. 45%
Bone Development and Growth Explanation: **65%**
- The inorganic component of bone, primarily **hydroxyapatite crystals**, makes up approximately **60-70%** of the bone's dry weight [1].
- This high percentage of inorganic material is responsible for the bone's **hardness and compressive strength**.
*85%*
- This percentage is **too high** for the inorganic component, as it would leave insufficient room for organic material, making bones exceedingly brittle and prone to fracture.
- While bone is very hard, reaching 85% inorganic content would significantly compromise its **flexibility and tensile strength**.
*35%*
- This percentage is **too low** for the inorganic component; such a composition would result in bones that are overly flexible and weak, unable to provide adequate structural support [1].
- Bones with only 35% inorganic material would lack the necessary **rigidity and resistance to deformation**.
*45%*
- While closer than 35%, 45% is still **below the typical range** for the inorganic component of bone.
- Such a composition would still lead to **reduced bone density** and increased susceptibility to fractures compared to normal bone.
Bone Development and Growth Indian Medical PG Question 10: Which statement is incorrect about the pathology of the bone tumor?
- A. Tumor has distinct margin
- B. Tumor arises from epiphyseal to metaphyseal region
- C. Eccentric lesion
- D. Chemotherapy is the treatment of choice for all bone tumors. (Correct Answer)
Bone Development and Growth Explanation: ***Tumor has distinct margin***
- A **distinct margin** often indicates a benign tumor, while malignant tumors typically show **infiltrative margins**.
- In bone tumors, particularly malignant ones, the lack of clear demarcation is a key pathological feature.
*Chemotherapy is the treatment of choice*
- While chemotherapy may be used for certain **malignant bone tumors**, it is not the first-line treatment for most bone tumors [1].
- The primary treatment is often **surgical excision**, especially for localized lesions [1].
*Tumor arise from epiphyseal to metaphyseal region*
- While some tumors can originate in these areas, many actually arise from the **diaphyseal** region in bone tumors like osteosarcoma.
- This option misrepresents the common locations where various tumors develop, as osteochondromas tend to develop near the epiphyses of limb bones [2].
*Eccentric lesion*
- Many bone tumors do indeed present as **eccentric lesions**, especially benign ones like **osteochondromas**.
- However, this feature does not apply universally, as some malignant tumors can also be **central or infiltrative** in nature.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 673-674.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 672-673.
More Bone Development and Growth Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
